Conflicts of interest and spin in reviews of psychological therapies: A systematic review

BMJ Open

Volumn 6, Issue 4, 2016, Pages

  Lieb, Klaus ^a   Von Der Osten Sacken, Jan ^a   Stoffers Winterling, Jutta ^a   Reiss, Neele ^b   Barth, Jürgen ^c  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACCELERATION; ANXIETY DISORDER; CONFLICT OF INTEREST; DEPRESSION; HUMAN; MEDICAL RESEARCH; MEDLINE; PERSONALITY DISORDER; PSYCHOTHERAPY; PSYCINFO; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; ANXIETY DISORDERS; COGNITIVE THERAPY; DEPRESSIVE DISORDER; PERSONALITY DISORDERS; PROCEDURES; STANDARDS; TREATMENT OUTCOME;

ANXIETY DISORDERS; COGNITIVE THERAPY; CONFLICT OF INTEREST; DEPRESSIVE DISORDER; HUMANS; PERSONALITY DISORDERS; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84971268517     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2015-010606     Document Type: Review

References (24)

1. Thompson DF. The challenge of conflict of interest in medicine. Z Evid Fortbild Qual Gesundhwes 2009;103:136-40.
2. Lo B, Field MJ, eds. Conflict of interest in medical research, education, and practice, Institute of Medicine, 2009.
3. Campbell EG. Doctors and drug companies-scrutinizing influential relationships. N Engl J Med 2007;357:1796-7.
4. Campbell EG, Rao SR, DesRoches CM, et al. Physician professionalism and changes in physician-industry relationships from 2004 to 2009. Arch Intern Med 2010;170:1820-6.
5. Campbell EG, Weissman JS, Ehringhaus S, et al. Institutional academic industry relationships. JAMA 2007;298:1779-86.
6. Lieb K, Brandtönies S. A survey of German physicians in private practice about contacts with pharmaceutical sales representatives. Dt Arztebl Int 2010;107:392-8.
7. Lieb K, Scheurich A. Contact between doctors and the pharmaceutical industry, their perceptions, and the effects on prescribing habits. PLoS ONE 2014;9:e110130.
8. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: A systematic review. JAMA 2003;289:454-65.
9. Schott G, Pachl H, Limbach U, et al. The financing of drug trials by pharmaceutical companies and its consequences. Part 1: A qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials. Dtsch Arztebl Int 2010;107:279-85.
10. Wang AT, McCoy CP, Murad MH, et al. Association between industry affiliation and position on cardiovascular risk with rosiglitazone: cross sectional systematic review. BMJ 2010;340: c1344.
11. Dunn AG, Arachi D, Hudgins J, et al. Financial conflicts of interest and conclusions about neuraminidase inhibitors for influenza: An analysis of systematic reviews. Ann Intern Med 2014;161:513-18.
12. Roest AM, De Jonge P, Williams CD, et al. Reporting bias in clinical trials investigating the efficacy of second-generation antidepressants in the treatment of anxiety disorders: A report of 2 meta-analyses. JAMA Psychiatry 2015;72:500-10.
13. Roseman M, Milette K, Bero LA, et al. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments. JAMA 2011;305:1008-17.
14. Roseman M, Turner EH, Lexchin J, et al. Reporting of conflicts of interest from drug trials in Cochrane reviews: cross sectional study. BMJ 2012;345:e5155.
15. Clark AM, Choby A, Ainsworth K, et al. Addressing conflict of interest in non-pharmacological research. Int J Clin Pract 2015;69:270-2.
16. Leykin Y, DeRubeis RJ. Allegiance in psychotherapy outcome research: separating association from bias. Clin Psychol Sci Pract 2009;16:54-65.
17. Lambert MJ. Are differential treatment effects inflated by researcher therapy allegiance? Could Clever Hans count? Clin Psychol Sci Pract 1999;6:127-30.
18. Gaffan EA, Tsaousis I, Kemp-Wheeler SM. Researcher allegiance and meta-analysis: The case of cognitive therapy for depression. J Consult Clin Psychol 1995;63:966-80.
19. Munder T, Gerger H, Trelle S, et al. Testing the allegiance bias hypothesis: A meta-analysis. Psychother Res 2011;21: 670-84.
20. Miller S, Wampold B, Varhely K. Direct comparisons of treatment modalities for youth disorders: A meta-analysis. Psychother Res 2008;18:5-14.
21. Munder T, Brütsch O, Leonhart R, et al. Researcher allegiance in psychotherapy outcome research: An overview of reviews. Clin Psychol Rev 2013;33:501-11.
22. Munder T, Flückiger C, Gerger H, et al. Is the allegiance effect an epiphenomenon of true efficacy differences between treatments? a meta-analysis. J Couns Psychol 2012;59:631-7.
23. Cuijpers P, Driessen E, Hollon SD, et al. The efficacy of non-directive supportive therapy for adult depression: A meta-analysis. Clin Psychol Rev 2012;32:280-91.
24. Cuijpers P, van Straten A, Bohlmeijer E, et al. The effects of psychotherapy for adult depression are overestimated: A meta-analysis of study quality and effect size. Psychol Med 2010;40:211-23.